PancreasPlus App Monitors Pancreatic Cancer Patients
Summary
NIH ClinicalTrials.gov registered study NCT07532590 evaluating the PancreasPlus mobile app for pancreatic cancer patients. The single-arm feasibility study will assess patient engagement, questionnaire completion rates, perceived service quality, and anxiety reduction through use of the app for remote symptom monitoring and caregiver support. The study anticipates enrolling patients over an undefined period with a primary completion date of April 16, 2026.
What changed
NIH added a new clinical trial registration (NCT07532590) for the PancreasPlus app study to evaluate feasibility, patient engagement, and perceived service quality in pancreatic cancer patients using the mobile application for remote monitoring. The study will measure questionnaire completion rates, anxiety levels using standardized scales (HADS-A), and quality of life metrics over the study period.
Healthcare providers considering similar digital health tools may find this study informative for evaluating patient engagement potential. The app does not replace clinical decision-making and is designed to supplement rather than substitute for hospital-based care coordination. Researchers and app developers in the digital health space may reference completion and usability outcomes when assessing similar patient monitoring technologies.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content.
N/A NCT07532590 Kind: NA Apr 16, 2026
Abstract
Caring for people with pancreatic cancer requires good coordination between hospital care and care at home, with different healthcare professionals working closely together. Patients are also becoming more involved in managing their own care on a daily basis. However, this active involvement can be difficult if there is poor communication with healthcare teams, differences in skills or familiarity with digital tools, or systems that do not support patient participation.
The PancreasPlus app was developed to support patients and caregivers by providing reliable information, self-monitoring tools, and a communication channel with healthcare professionals. The study aims to assess the feasibility, patient engagement, and perceived quality of routine use of the app. It is hypothesized that its use will improve engagement, perceived quality, reduce anxiety and unplanned hospital visits, without introducing technological or privacy risks. The app supports information and data collection but does not replace clinical decision-making.
Objectives
Primary objectives:
Assess feasibility and patient engagement through questionnaire completion. Evaluate perceived service quality using the Client Satisfaction Questionnaire (CSQ-8).
Secondary objectives:
Monitor unplanned hospital visits and adherence to chemotherapy. Assess anxiety (HADS-A), nutritional status, and global quality of life (PROMIS Global).
Evaluate usability and acceptability of the app (SUS, UTAUT2 short version)....
Conditions: Ductal Adenocarcinoma of Pancreas, Pancreatectomy, Caregiver, Nutritional Evaluation, Post Surgery Patients, Pain Management
Interventions: use of PancreasPlus app
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.